Day: September 19, 2023

Study met the primary endpoint and all secondary endpoints, highly consistent with rapid response from the INTEGUMENT-1 and INTEGUMENT-2 pivotal trials For the primary endpoint, 25.4% of children treated once daily with roflumilast cream 0.05% achieved Investigator Global Assessment (IGA) Success compared to 10.7% of children treated with vehicle (P

TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its executive management team will participate in the following upcoming conferences in September. ATB Capital Markets Life Sciences Institutional Investor Conference, September 20, 2023, in New York City: Ziad Ghanem, TerrAscend’s Chief Executive Officer, and Noah Hamman, Founder and CEO of AdvisorShares, will participate in a panel discussion titled “The Quest for Trading Liquidity and Institutional Investors” at 11:15 AM ET. For more information, please contact your ATB representative. Benzinga Cannabis Capital Conference, September 27-28, 2023, in Chicago: Jason Wild, Executive Chairman, will be the keynote speaker at 9:30...

Hypertension is the most common comorbidity in the pacemaker population, affecting over 70% of patients or approximately 750,000 people annually worldwide Medtronic plc and Orchestra BioMed have an exclusive strategic collaboration for global development and commercialization of BackBeat Cardiac Neuromodulation Therapy™ (CNT), now also known as Atrioventricular Interval Modulation (“AVIM”) therapy, for hypertensive pacemaker patients BACKBEAT global pivotal study is expected to start before the end of 2023 IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients Orchestra BioMed management to host conference call today, September 19, 2023, at 8:30am ETNEW HOPE, Pa., Sept. 19, 2023 (GLOBE NEWSWIRE)...

Figure 1Longitudinal View of the Kiena Mine ComplexFigure 2Longitudinal View of the Presquile DepositTORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO) (“Wesdome” or the “Company”) today announces the 2023 surface exploration drilling results from the Presqu’île Zone located 1.3 km north-west of the Company’s 100% owned Kiena Mine Complex in Val d’Or, Quebec. Recent drilling at Presqu’île is part of an ongoing exploration program focussing on near surface gold potential along strike from Kiena that remains under explored. Drilling results from the Shawkey and Dubuisson Zones, located further to the east along strike, were released earlier this year (see May 23, 2023 release, “Wesdome Drilling Southeast of Kiena Mine Identifies Potential Bulk Tonnage Underground Target; Returning...

This is the first of seven fuselages for the seven aircraft Lilium will use to achieve type-certification of the Lilium Jet Pivotal and tangible step towards the industrialization of the Lilium Jet Fuselage being assembled at Aciturri’s state-of-the-art manufacturing facility in SpainMUNICH, Germany, Sept. 19, 2023 (GLOBE NEWSWIRE) — Lilium N.V. (NASDAQ: LILM), developer of the first all-electric vertical take-off and landing (“eVTOL”) jet, announced that it has achieved a significant development milestone with the commencement of fuselage assembly for the Lilium Jet, which remains on track for expected first manned flight planned in late 2024. Start of fuselage assembly serves as another tangible manifestation of Lilium’s strategic roadmap, demonstrating Lilium’s ability to progress from vision to execution. This is the first...

CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the Jefferies Cell & Genetic Medicine Summit on Tuesday, September 26, 2023 at 9:30 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event. About Generation Bio   Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral genetic medicine platform incorporates...

SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the upcoming Cantor Global Healthcare Conference 2023 being held in New York. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a fireside chat at 10:55 a.m. ET / 7:55 a.m. PT on September 26, 2023. A live audio webcast of the fireside chat will be available in the investor section of Kura’s website at www.kuraoncology.com with an archived replay available following the live event. About Kura Oncology Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer....